SEPN

Septerna, Inc.

Healthcare · Biotechnology

$126.29 sample

-1.05 (-0.82%) 1D

Market cap

$262.3B

Price as of

2026-10-03

Latest filing

8-K · 2026-09-14

Alerts

8

Price$126.29 +6.64% 3M daily closessample

135.68114.01

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 22INSInsider sell: General Counsel
Sep 14SEC10-Q filed
Sep 08SECForm 144 filed
Aug 28INSInsider sell: EVP, Operations
Aug 24INSInsider sell: EVP, Operations
Aug 18INSInsider buy: EVP, Operations
Aug 11INSInsider sell: General Counsel
Aug 03INSInsider buy: 10% owner

Sign up to see the real SEPN record →

Company facts

SEC EDGAR registration

Name: Septerna, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +14sample, -100 to +100
Reporting currency: USD

Who is positioning in SEPN

sample

Insiders: 26 insider transactions over 90 days, net selling, $127.2M
Congress: 4 members traded over 90 days
Institutions · 13F: 17 funds hold $4.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$9.7B +15.8% y/y

Q4 2024Q3 2026

Inventory$5.7B +9.2% y/y

Q4 2024Q3 2026

Accounts receivable$4.3B +16.4% y/y

Q4 2024Q3 2026

Total debt$11.6B +13.7% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $45.7B +15.4% 3M
Sample peer B: $195.5B -12.3% 3M
Sample peer C: $201.8B +11.3% 3M
Sample peer D: $166.4B +15.6% 3M
Sample peer E: $146.3B +14.1% 3M